• linkedin
  • Increase Font
  • Sharebar

    Focal cryo vs. focal HIFU: Similar oncologic outcomes

    Difference in failure rates not statistically significant, researchers report

    London—Oncologic outcomes are similar using focal cryotherapy and focal high-intensity focused ultrasound (HIFU) for treatment of localized prostate cancer, French urologists reported at the World Congress of Endourology and SWL in London.  

    Read: AUA, others fight measure penalizing docs who order PSA

    Their study analyzed prospectively collected data from patients who were followed for at least 1 year after being treated with focal therapy through the Paris-based Institut Mutualiste Montsouris (IMM) department of urology. Control biopsies were obtained routinely at 1 year in all patients and then after 2 or 3 years, regardless of PSA, according to the treating physician’s discretion.

    There were 91 men who had undergone focal cryotherapy and 58 who had focal HIFU. Median follow-up was 22 months for the cryotherapy group and 19 months for HIFU patients. Any positive follow-up biopsy was considered treatment failure, and it was found in 43 men (47%) who had cryotherapy and 18 of the men (31%) who had HIFU. The difference in rates was not statistically significant.

    Also see: Can Gleason 7 cancer be low-risk disease?

    In the cryotherapy and HIFU groups, the positive biopsy was ipsilateral in 14 (15.4%) and eight (13.8%) men, respectively; contralateral in 14 (15.4%) and seven (12.1%) men, respectively; and bilateral in 15 (16.5%) and three men (5.2%), respectively. Fifteen men in the cryotherapy group and four in the HIFU group had a Gleason 7 positive biopsy and underwent salvage radical prostatectomy. Thirteen cryotherapy patients and three HIFU patients had one ipsilateral Gleason 6 positive biopsy. Of those 16 patients, nine underwent repeat focal therapy and seven chose active surveillance.

    Next: "Our experience indicates that failure rates are comparable after focal cryotherapy and focal HIFU."


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available